Morgan Stanley’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.4K Hold
20,475
﹤0.01% 6437
2026
Q1
$20.5K Hold
20,475
﹤0.01% 6720
2025
Q4
$6.96K Buy
+20,475
New +$6.9K ﹤0.01% 6981
2025
Q2
Sell
-2,545
Closed -$605 8144
2025
Q1
$605 Hold
2,545
﹤0.01% 7348
2024
Q4
$534 Hold
2,545
﹤0.01% 7339
2024
Q3
$484 Hold
2,545
﹤0.01% 7303
2024
Q2
$515 Hold
2,545
﹤0.01% 7225
2024
Q1
$637 Hold
2,545
﹤0.01% 7217
2023
Q4
$490 Hold
2,545
﹤0.01% 7205
2023
Q3
$643 Hold
2,545
﹤0.01% 7282
2023
Q2
$1.01K Hold
2,545
﹤0.01% 7292
2023
Q1
$713 Hold
2,545
﹤0.01% 7387
2022
Q4
$637 Hold
2,545
﹤0.01% 7532
2022
Q3
$1K Hold
2,545
﹤0.01% 7554
2022
Q2
$1K Hold
2,545
﹤0.01% 7668
2022
Q1
$2K Buy
+2,545
New +$1.39K ﹤0.01% 7730

Other funds holding DRTSW

Morgan Stanley's DRTSW Position: Q2 2026 in Review

Morgan Stanley held its Alpha Tau Medical Warrant (DRTSW) position steady in Q2 2026 at 20,475 shares worth $60.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6437.

Morgan Stanley first reported a position in DRTSW in Q1 2022 and has held it in 16 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • Morgan Stanley held 20,475 shares of Alpha Tau Medical Warrant worth $60.4K as of Q2 2026.
  • Morgan Stanley left its Alpha Tau Medical Warrant share count unchanged in Q2 2026.
  • Alpha Tau Medical Warrant made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6437 holding.
  • Morgan Stanley first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 16 quarters since.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.